India Pharmaceutical Packaging Market, By Product Type (Specialty Bags( Urinary collection bags, Bile collection bags, Blood bags, Sterile packaging bags, Enteral feeding), Parenteral Container (Bags, Bottles, Ampoules, Vials, Cartridges, Others parenteral container, Others)), By Material Type (Glass, Aluminum foils, Plastics and polymers, Paper & paperboards, Others)

Published In : Sep 2023

Code : CMI5284

Pages :115

Formats :

Excel and PDF

Industry : Packaging

Market News

India Pharmaceutical Packaging Market: Key Developments

In July 2022, the consumer health division of Cipla (Cipla) entered into a definitive contract to acquire Endura Mass (Endura Mass Weight Gain), a nutritional supplement for weight gain, from the private limited liability company Medinnbelle Herbalcare Pvt.Ltd. for an undisclosed sum.

In May 2022, Hong Kong-Nun Corporation (HK.N. Corporation) entered into an exclusive co-operation agreement with the Indian pharmaceutical and biopharmaceutical research and development company Dr.Reddy's Laboratories to supply and commercialize the patented novel molecule of HK.N. corporation, Tegoprazane, for the treatment of gastrointestinal diseases in the Indian market and six key emerging markets.

In June 2022, Glenmark Pharmaceuticals Limited, a global pharmaceutical company focused on innovation, launched a novel fixed-dose combination drug, Indacaterol+Mometasone, in India for the treatment of patients with uncontrolled asthma. The company has launched the Fixed-dose combination under its Indamet brand, and the medication will be available in three strengths: indacaterol (150 mcg), mometasone (80 mcg), and 320 mcg (160 mcg) once daily.

In March 2022, VIRALEX, an antiviral drug developed by Themis Medicare Ltd. Has granted marketing authorization by the DCGI. Double-blind, randomized, and compound (RCT) clinical trials have demonstrated that the drug aids in the initial relief of clinical symptoms in patients with mild to moderate COVID-19 infection.